PackerDLMarkDBRobbRA, et al.
Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA Randomized Clinical Trial. JAMA2019;
321: 1261–1274.
2.
HuxleyRRLopezFLFolsomAR, et al.
Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation2011;
123: 1501–1508.
3.
ChamberlainAMAgarwalSKAmbroseM, et al.
Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J2010;
159: 850–856.
4.
PallisgaardJLSchjerningA-MLindhardtTB, et al.
Risk of atrial fibrillation in diabetes mellitus: a nationwide cohort study. Eur J Prev Cardiol2016;
23: 621–627.
5.
Lee Y, Cha SJ, Park JH et al. Association between insulin resistance and risk of atrial fibrillation in non-diabetics. Eur J Prev Cardiol, 2020; 27: 1934–1941.
6.
MatthewsDRHoskerJPRudenskiAS, et al.
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia1985;
28: 412–419.
7.
VardenyOGuptaDKClaggettB, et al.
Insulin resistance and incident heart failure the ARIC study (Atherosclerosis Risk in Communities). JACC Heart Fail2013;
1: 531–536.
8.
Gayoso-DizPOtero-GonzálezARodriguez-AlvarezMX, et al.
Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocrine Disord2013;
13: 47.
9.
FontesJDLyassAMassaroJM, et al.
Insulin resistance and atrial fibrillation (from the Framingham Heart Study).Am J Cardiol2012;
109: 87–90.
10.
GargPKBiggsMLKaplanR, et al.
Fasting and post-glucose load measures of insulin resistance and risk of incident atrial fibrillation: the Cardiovascular Health Study. Nutr Metab Cardiovasc Dis2018;
28: 716–721.
11.
BakkerLESledderingMASchoonesJW, et al.
Pathogenesis of type 2 diabetes in South Asians. Eur J Endocrinol2013;
169: R99–R114.
12.
PerssonCEAdielsMBjörckL, et al.
Young women, body size and risk of atrial fibrillation. Eur J Prev Cardiol2018;
25: 173–180.
13.
SuskinNGHeigenhauserGAfzalR, et al.
The effects of exercise training on insulin resistance in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil2007;
14: 803–808.
14.
MorsethBLøchenM-LAriansenI, et al.
The ambiguity of physical activity, exercise and atrial fibrillation. Eur J Prev Cardiol2018;
25: 624–636.
15.
HellgrenMIDakaBJanssonP-A, et al.
Insulin resistance predicts early cardiovascular morbidity in men without diabetes mellitus, with effect modification by physical activity. Eur J Prev Cardiol2015;
22: 940–949.
16.
PolovinaMHindricksGMaggioniA, et al.
Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation. Eur Heart J2018;
39: 4030–4039.
